Thomas Woiwode Insider Trading $ALGS Aligos Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Woiwode.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Woiwode. Thomas Woiwode is Director in Adverum Biotechnologies, Inc. ($AAVL) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Gritstone Oncology, Inc. ($GRTS) and Director in Passage BIO, Inc. ($PASG) and Director in Aligos Therapeutics, Inc. ($ALGS).
Thomas Woiwode in Aligos Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 1,943,916 shares
Latest Transaction: Apr 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Thomas Woiwode in Aligos Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, ALGS, BOLD, CRSP, GRTS, PASG
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 2,226 | 0 | 2,226 | 0 to 2.2 K |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Sell | J | 0.00 | 8,385 | 0 | 0 | 8.4 K to 0 (-100.00 %) |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 8,385 | 0 | 8,385 | 0 to 8.4 K |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Sell | J | 0.00 | 9,720 | 0 | 0 | 9.7 K to 0 (-100.00 %) |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 9,720 | 0 | 9,720 | 0 to 9.7 K |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Sell | J | 0.00 | 485,979 | 0 | 1,943,916 | 2.4 M to 1.9 M (-20.00 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 198,485 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 85,065 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 463,959 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 198,839 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 2,145,991 | 0 | 0 | |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | P | 15.00 | 200,000 | 3,000,000 | 862,444 | 662.4 K to 862.4 K (+30.19 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 198,485 | 0 | 662,444 | 464 K to 662.4 K (+42.78 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 463,959 | 0 | 463,959 | 0 to 464 K |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 85,065 | 0 | 2,429,895 | 2.3 M to 2.4 M (+3.63 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 198,839 | 0 | 2,344,830 | 2.1 M to 2.3 M (+9.27 %) |
| Oct 20 2020 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 2,145,991 | 0 | 2,145,991 | 0 to 2.1 M |
Page: 1